← Alle mensen

TM

T Mok

7 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Alectinib versus crizotinib in previously untreated ALK-positive gevorderd non-small cell lung cancer: final totale o...
Annals of oncology : official journal of the European Society for Medical Oncology · 2026-01
EGFR-gemuteerd NSCLC: ESMO expertconsensus
Annals of oncology : official journal of the European Society for Medical Oncology · 2022-05
Geactualiseerde OS en PFS van CheckMate 214: nivolumab-ipilimumab bij mRCC
Annals of oncology : official journal of the European Society for Medical Oncology · 2020-08
Alectinib versus crizotinib bij ALK-positief NSCLC: ALEX geactualiseerde analyse
Annals of oncology : official journal of the European Society for Medical Oncology · 1 november 2018
Afatinib versus gefitinib bij EGFR-mutatiepositief NSCLC: totale overleving van LUX-Lung 7
Annals of oncology : official journal of the European Society for Medical Oncology · 1 februari 2017
Effect van dosisaanpassing op veiligheid en werkzaamheid van afatinib bij EGFR-mutatiepositief longadenocarcinoom
Annals of oncology : official journal of the European Society for Medical Oncology · 2016-11
Dacomitinib versus erlotinib bij EGFR-gemuteerd gevorderd NSCLC
Annals of oncology : official journal of the European Society for Medical Oncology · 2016-03